An evaluation of the additive effect of natural herbal medicine on SARS or SARS-like infectious diseases in 2003: A randomized, double-blind, and controlled pilot study

Chung Hua Hsu, Kung Chang Hwang, Chung Liang Chao, Steve G.N. Chang, Mei Shang Ho, Jaung Geng Lin, Hen Hong Chang, Shung Te Kao, Yi Ming Chen, Pesus Chou

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Natural herbal medicine (NHM) has been used to control infectious diseases for thousands of years. In view of the possible beneficial effect of NHM on SARS, we conducted this study to examine whether NHM is of any benefit as a supplementary treatment of SARS or SARS-like infectious disease. This was a randomized, double-blind, placebo-controlled trial. Twenty-eight patients fulfilled the WHO inclusion criteria and our exclusion criteria. All enrolled patients received routine western-medicine treatment. Patients were randomly allocated to one of the three supplementary treatment groups: NHM A (Group A, n = 9) NHM B (Group B, n = 9) or placebo (Group C, n = 10). Chest X-ray was done every 1 or 2 days for every patient. Reading radiologists use a standard 0-3 scoring system (0: no infiltration; 1: focal haziness or even small patchy lesion; 2: ground glass picture; 3: lobar consolidation) according to the severity of infiltration in each lung field (three lung fields in both right and left lungs). The main outcome measurements were the improving chest radiographic scores (IRS) and the duration (days) till improvement (DI). One patient from the placebo group passed away. Patients from NHM A took less days before showing improvement (6.7 ± 1.8) compared with placebo group (11.2 ± 4.9), which showed statistical significance (P = 0.04). The cases were too few to be conclusive, the initial observations seem to indicate NHM appears to be safe in non-criticallly ill patients and clinical trials are feasible in the setting of pandemic outbreaks.

Original languageEnglish
Pages (from-to)355-362
Number of pages8
JournalEvidence-based Complementary and Alternative Medicine
Volume5
Issue number3
DOIs
Publication statusPublished - Sep 1 2008
Externally publishedYes

Fingerprint

Herbal Medicine
Communicable Diseases
Placebos
Lung
Thorax
Pandemics
Glass
Disease Outbreaks
Reading
Therapeutics
X-Rays
Medicine
Clinical Trials

Keywords

  • Avian influenza
  • Nature herbal medicine
  • SARS

ASJC Scopus subject areas

  • Complementary and alternative medicine

Cite this

An evaluation of the additive effect of natural herbal medicine on SARS or SARS-like infectious diseases in 2003 : A randomized, double-blind, and controlled pilot study. / Hsu, Chung Hua; Hwang, Kung Chang; Chao, Chung Liang; Chang, Steve G.N.; Ho, Mei Shang; Lin, Jaung Geng; Chang, Hen Hong; Kao, Shung Te; Chen, Yi Ming; Chou, Pesus.

In: Evidence-based Complementary and Alternative Medicine, Vol. 5, No. 3, 01.09.2008, p. 355-362.

Research output: Contribution to journalArticle

Hsu, Chung Hua ; Hwang, Kung Chang ; Chao, Chung Liang ; Chang, Steve G.N. ; Ho, Mei Shang ; Lin, Jaung Geng ; Chang, Hen Hong ; Kao, Shung Te ; Chen, Yi Ming ; Chou, Pesus. / An evaluation of the additive effect of natural herbal medicine on SARS or SARS-like infectious diseases in 2003 : A randomized, double-blind, and controlled pilot study. In: Evidence-based Complementary and Alternative Medicine. 2008 ; Vol. 5, No. 3. pp. 355-362.
@article{df1cc41103cc43a1bb1473f900b0a91d,
title = "An evaluation of the additive effect of natural herbal medicine on SARS or SARS-like infectious diseases in 2003: A randomized, double-blind, and controlled pilot study",
abstract = "Natural herbal medicine (NHM) has been used to control infectious diseases for thousands of years. In view of the possible beneficial effect of NHM on SARS, we conducted this study to examine whether NHM is of any benefit as a supplementary treatment of SARS or SARS-like infectious disease. This was a randomized, double-blind, placebo-controlled trial. Twenty-eight patients fulfilled the WHO inclusion criteria and our exclusion criteria. All enrolled patients received routine western-medicine treatment. Patients were randomly allocated to one of the three supplementary treatment groups: NHM A (Group A, n = 9) NHM B (Group B, n = 9) or placebo (Group C, n = 10). Chest X-ray was done every 1 or 2 days for every patient. Reading radiologists use a standard 0-3 scoring system (0: no infiltration; 1: focal haziness or even small patchy lesion; 2: ground glass picture; 3: lobar consolidation) according to the severity of infiltration in each lung field (three lung fields in both right and left lungs). The main outcome measurements were the improving chest radiographic scores (IRS) and the duration (days) till improvement (DI). One patient from the placebo group passed away. Patients from NHM A took less days before showing improvement (6.7 ± 1.8) compared with placebo group (11.2 ± 4.9), which showed statistical significance (P = 0.04). The cases were too few to be conclusive, the initial observations seem to indicate NHM appears to be safe in non-criticallly ill patients and clinical trials are feasible in the setting of pandemic outbreaks.",
keywords = "Avian influenza, Nature herbal medicine, SARS",
author = "Hsu, {Chung Hua} and Hwang, {Kung Chang} and Chao, {Chung Liang} and Chang, {Steve G.N.} and Ho, {Mei Shang} and Lin, {Jaung Geng} and Chang, {Hen Hong} and Kao, {Shung Te} and Chen, {Yi Ming} and Pesus Chou",
year = "2008",
month = "9",
day = "1",
doi = "10.1093/ecam/nem035",
language = "English",
volume = "5",
pages = "355--362",
journal = "Evidence-based Complementary and Alternative Medicine",
issn = "1741-427X",
publisher = "Hindawi Publishing Corporation",
number = "3",

}

TY - JOUR

T1 - An evaluation of the additive effect of natural herbal medicine on SARS or SARS-like infectious diseases in 2003

T2 - A randomized, double-blind, and controlled pilot study

AU - Hsu, Chung Hua

AU - Hwang, Kung Chang

AU - Chao, Chung Liang

AU - Chang, Steve G.N.

AU - Ho, Mei Shang

AU - Lin, Jaung Geng

AU - Chang, Hen Hong

AU - Kao, Shung Te

AU - Chen, Yi Ming

AU - Chou, Pesus

PY - 2008/9/1

Y1 - 2008/9/1

N2 - Natural herbal medicine (NHM) has been used to control infectious diseases for thousands of years. In view of the possible beneficial effect of NHM on SARS, we conducted this study to examine whether NHM is of any benefit as a supplementary treatment of SARS or SARS-like infectious disease. This was a randomized, double-blind, placebo-controlled trial. Twenty-eight patients fulfilled the WHO inclusion criteria and our exclusion criteria. All enrolled patients received routine western-medicine treatment. Patients were randomly allocated to one of the three supplementary treatment groups: NHM A (Group A, n = 9) NHM B (Group B, n = 9) or placebo (Group C, n = 10). Chest X-ray was done every 1 or 2 days for every patient. Reading radiologists use a standard 0-3 scoring system (0: no infiltration; 1: focal haziness or even small patchy lesion; 2: ground glass picture; 3: lobar consolidation) according to the severity of infiltration in each lung field (three lung fields in both right and left lungs). The main outcome measurements were the improving chest radiographic scores (IRS) and the duration (days) till improvement (DI). One patient from the placebo group passed away. Patients from NHM A took less days before showing improvement (6.7 ± 1.8) compared with placebo group (11.2 ± 4.9), which showed statistical significance (P = 0.04). The cases were too few to be conclusive, the initial observations seem to indicate NHM appears to be safe in non-criticallly ill patients and clinical trials are feasible in the setting of pandemic outbreaks.

AB - Natural herbal medicine (NHM) has been used to control infectious diseases for thousands of years. In view of the possible beneficial effect of NHM on SARS, we conducted this study to examine whether NHM is of any benefit as a supplementary treatment of SARS or SARS-like infectious disease. This was a randomized, double-blind, placebo-controlled trial. Twenty-eight patients fulfilled the WHO inclusion criteria and our exclusion criteria. All enrolled patients received routine western-medicine treatment. Patients were randomly allocated to one of the three supplementary treatment groups: NHM A (Group A, n = 9) NHM B (Group B, n = 9) or placebo (Group C, n = 10). Chest X-ray was done every 1 or 2 days for every patient. Reading radiologists use a standard 0-3 scoring system (0: no infiltration; 1: focal haziness or even small patchy lesion; 2: ground glass picture; 3: lobar consolidation) according to the severity of infiltration in each lung field (three lung fields in both right and left lungs). The main outcome measurements were the improving chest radiographic scores (IRS) and the duration (days) till improvement (DI). One patient from the placebo group passed away. Patients from NHM A took less days before showing improvement (6.7 ± 1.8) compared with placebo group (11.2 ± 4.9), which showed statistical significance (P = 0.04). The cases were too few to be conclusive, the initial observations seem to indicate NHM appears to be safe in non-criticallly ill patients and clinical trials are feasible in the setting of pandemic outbreaks.

KW - Avian influenza

KW - Nature herbal medicine

KW - SARS

UR - http://www.scopus.com/inward/record.url?scp=51849095507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51849095507&partnerID=8YFLogxK

U2 - 10.1093/ecam/nem035

DO - 10.1093/ecam/nem035

M3 - Article

AN - SCOPUS:51849095507

VL - 5

SP - 355

EP - 362

JO - Evidence-based Complementary and Alternative Medicine

JF - Evidence-based Complementary and Alternative Medicine

SN - 1741-427X

IS - 3

ER -